Illumina Body Map 2: averaged replicates
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXB6 | hg19_v2_chr17_-_46682321_46682362 | -0.20 | 2.8e-01 | Click! |
PRRX2 | hg19_v2_chr9_+_132427883_132427951 | 0.02 | 9.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_7382745 Show fit | 31.40 |
ENST00000436368.2
ENST00000311745.5 ENST00000355637.4 ENST00000340209.4 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
|
chr12_-_16761007 Show fit | 24.82 |
ENST00000354662.1
ENST00000441439.2 |
LIM domain only 3 (rhombotin-like 2) |
|
chr2_-_50201327 Show fit | 24.41 |
ENST00000412315.1
|
neurexin 1 |
|
chr7_+_107110488 Show fit | 17.72 |
ENST00000304402.4
|
G protein-coupled receptor 22 |
|
chr12_-_16761117 Show fit | 17.53 |
ENST00000538051.1
|
LIM domain only 3 (rhombotin-like 2) |
|
chr3_-_181160240 Show fit | 16.54 |
ENST00000460993.1
|
RP11-275H4.1 |
|
chr2_+_162272605 Show fit | 14.60 |
ENST00000389554.3
|
T-box, brain, 1 |
|
chr18_+_32290218 Show fit | 13.99 |
ENST00000348997.5
ENST00000588949.1 ENST00000597599.1 |
dystrobrevin, alpha |
|
chr5_-_88120083 Show fit | 13.73 |
ENST00000509373.1
|
myocyte enhancer factor 2C |
|
chr1_-_217250231 Show fit | 13.39 |
ENST00000493748.1
ENST00000463665.1 |
estrogen-related receptor gamma |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.1 | 112.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 63.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.2 | 54.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.6 | 50.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
1.8 | 41.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.5 | 41.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 35.5 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
4.8 | 33.8 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.4 | 33.4 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.5 | 30.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 170.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 69.8 | GO:0098794 | postsynapse(GO:0098794) |
0.2 | 65.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.3 | 49.2 | GO:0042383 | sarcolemma(GO:0042383) |
1.2 | 47.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.9 | 41.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 41.9 | GO:0031430 | M band(GO:0031430) |
0.2 | 32.8 | GO:0031674 | I band(GO:0031674) |
2.9 | 31.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 30.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 66.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 59.9 | GO:0005516 | calmodulin binding(GO:0005516) |
0.3 | 59.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 52.8 | GO:0005509 | calcium ion binding(GO:0005509) |
1.0 | 49.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 47.7 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.2 | 47.3 | GO:0051015 | actin filament binding(GO:0051015) |
1.4 | 47.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 41.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
4.7 | 37.9 | GO:0050682 | AF-2 domain binding(GO:0050682) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 49.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 27.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 25.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 21.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 18.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 17.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 15.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 15.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 13.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 12.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 68.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.4 | 50.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 34.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 31.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.9 | 29.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 28.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.2 | 28.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.5 | 25.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 22.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 18.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |